ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Frontida Expands Testing Capabilities contractpharma
February 03, 2021?Frontida BioPharm has launched its new Category 1 (CAT.ONE) in vitro testing and evaluation services to support development and regulatory approvals for abuse-deterrent formulations of pain management and Central Nervous System (CNS) targeted therapies.
Pharma Sources Insight July 2025
